# Phoenix Education Partners, Inc.: financial statements, quarterly

PXED · NYSE · CIK 1600222 · [Other](/sectors/other.md) · fiscal year ends Aug 31

Pages: [Overview](/companies/pxed.md) · [Financials](/companies/pxed/financials.md) · [Filings](/companies/pxed/filings.md) · [Insiders](/companies/pxed/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pxed/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-11-30) | period not labelled (2025-02-28) | period not labelled (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [255](/filings/0001193125-26-011745.md) | [223](/filings/0001193125-26-145546.md) | [272](/filings/0001193125-26-303175.md) | [262](/filings/0001193125-26-011745.md) | [222](/filings/0001193125-26-145546.md) | [272](/filings/0001193125-26-303175.md) |
| Operating income | $m | [59.7](/filings/0001193125-26-011745.md) | [19.7](/filings/0001193125-26-145546.md) | [71.1](/filings/0001193125-26-303175.md) | [25.6](/filings/0001193125-26-011745.md) | [14.0](/filings/0001193125-26-145546.md) | [51.8](/filings/0001193125-26-303175.md) |
| Interest expense | $m | [0.1](/filings/0001193125-26-011745.md) | [0.1](/filings/0001193125-26-145546.md) | [0.1](/filings/0001193125-26-303175.md) | [0.2](/filings/0001193125-26-011745.md) | [0.6](/filings/0001193125-26-145546.md) | [0.7](/filings/0001193125-26-303175.md) |
| Income tax | $m | [16.3](/filings/0001193125-26-011745.md) | [5.6](/filings/0001193125-26-145546.md) | [18.6](/filings/0001193125-26-303175.md) | [11.7](/filings/0001193125-26-011745.md) | [4.8](/filings/0001193125-26-145546.md) | [14.5](/filings/0001193125-26-303175.md) |
| Net income | $m | [46.4](/filings/0001193125-26-011745.md) | [16.1](/filings/0001193125-26-145546.md) | [53.8](/filings/0001193125-26-303175.md) | [15.5](/filings/0001193125-26-011745.md) | [10.8](/filings/0001193125-26-145546.md) | [39.2](/filings/0001193125-26-303175.md) |
| Diluted EPS | $ per share | [1.23](/filings/0001193125-26-011745.md) | [0.43](/filings/0001193125-26-145546.md) | [1.42](/filings/0001193125-26-303175.md) | [0.40](/filings/0001193125-26-011745.md) | [0.28](/filings/0001193125-26-145546.md) | [1.01](/filings/0001193125-26-303175.md) |
| Basic EPS | $ per share | [1.31](/filings/0001193125-26-011745.md) | [0.45](/filings/0001193125-26-145546.md) | [1.51](/filings/0001193125-26-303175.md) | [0.43](/filings/0001193125-26-011745.md) | [0.30](/filings/0001193125-26-145546.md) | [1.09](/filings/0001193125-26-303175.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-08-31) | period not labelled (2024-11-30) | period not labelled (2025-02-28) | period not labelled (2025-05-31) | period not labelled (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [262](/filings/0001193125-26-011745.md) | [166](/filings/0001193125-26-145546.md) | [203](/filings/0001193125-26-303175.md) | [137](/filings/0001193125-26-303175.md) | [151](/filings/0001193125-26-011745.md) | [195](/filings/0001193125-26-145546.md) | [155](/filings/0001193125-26-303175.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [266](/filings/0001193125-26-303175.md) | [316](/filings/0001193125-26-011745.md) | [317](/filings/0001193125-26-145546.md) | [361](/filings/0001193125-26-303175.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [494](/filings/0001193125-26-303175.md) | [550](/filings/0001193125-26-011745.md) | [546](/filings/0001193125-26-145546.md) | [609](/filings/0001193125-26-303175.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [162](/filings/0001193125-26-303175.md) | [168](/filings/0001193125-26-011745.md) | [158](/filings/0001193125-26-145546.md) | [188](/filings/0001193125-26-303175.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [254](/filings/0001193125-26-303175.md) | [266](/filings/0001193125-26-011745.md) | [253](/filings/0001193125-26-145546.md) | [282](/filings/0001193125-26-303175.md) |
| Shareholders' equity | $m | [349](/filings/0001193125-26-303175.md) | [400](/filings/0001193125-26-145546.md) | [269](/filings/0001193125-26-303175.md) | [324](/filings/0001193125-26-303175.md) | [247](/filings/0001193125-26-303175.md) | [280](/filings/0001193125-26-011745.md) | [291](/filings/0001193125-26-145546.md) | [324](/filings/0001193125-26-303175.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-11-30) | period not labelled (2025-02-28) | period not labelled (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(34.0)](/filings/0001193125-26-011745.md) | [56.2 d](/filings/0001193125-26-145546.md) | [29.6 d](/filings/0001193125-26-303175.md) | [31.1](/filings/0001193125-26-011745.md) | [48.9 d](/filings/0001193125-26-145546.md) | [36.7 d](/filings/0001193125-26-303175.md) |
| Capital expenditure | $m | [5.8](/filings/0001193125-26-011745.md) | [5.1 d](/filings/0001193125-26-145546.md) | [5.5 d](/filings/0001193125-26-303175.md) | [4.7](/filings/0001193125-26-011745.md) | [5.4 d](/filings/0001193125-26-145546.md) | [4.9 d](/filings/0001193125-26-303175.md) |
| Dividends paid | $m | [0.1](/filings/0001193125-26-011745.md) | [(0.1) d](/filings/0001193125-26-145546.md) | [0.0 d](/filings/0001193125-26-303175.md) | [0.7](/filings/0001193125-26-011745.md) | [8.3 d](/filings/0001193125-26-145546.md) | [8.3 d](/filings/0001193125-26-303175.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | period not labelled (2024-11-30) | period not labelled (2025-02-28) | period not labelled (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.6](/filings/0001193125-26-011745.md) | [37.9](/filings/0001193125-26-145546.md) | [38.0](/filings/0001193125-26-303175.md) | [38.9](/filings/0001193125-26-011745.md) | [38.9](/filings/0001193125-26-145546.md) | [38.9](/filings/0001193125-26-303175.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,047,376 at 2026-07-07, from the cover of the [10-Q filed 2026-07-14](/filings/0001193125-26-303175.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.